Latest Reported Offering
$50,000
Target Amount
$500,000
Maximum Amount
2025-04-30
Deadline
Security Details
Type: Other
Price per share: $1.00
Price set by: Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
Shares offered: 50,000+
Offering Costs
Cash commission: 7%
of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: —
No
Filing history
Form C family — 2 filings| Filed | Form | File number | Portal | What it states | What the filer said |
|---|---|---|---|---|---|
| 2025-03-14 | C-AR | 020-33781 | Wefunder | Revenue $0 · net income -$241K · 0 employees | — |
| 2024-03-12 | C | 020-33781 | Wefunder | $50K target, up to $500K · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2025-04-30 | — |
The reported figures behind Innovative Therapeutix, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Latest Metrics
Employees0
Total Assets$341,923
Cash on Hand$341,923
Revenues$0.00
Net Income-$240,517
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.